<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the roles of granulocyte colony-stimulating factor in the pathogenesis of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Serum G-CSF concentrations were measured using enzyme linked immunosorbent assay (ELISA) in 20 children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and 20 healthy children </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Serum G-CSF concentration (35.7+/-10.3 pg/mL) in children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> was significantly higher than that in healthy controls (23.5+/-3.8 pg/mL) (p&lt;0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSIONS: The elevated serum G-CSF concentration in children with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> suggests that G-CSF may play an important role in the pathogenesis of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
</text></document>